Chemoinformaics analysis of Methyl 11,14,17,Eicosatrienoate
| Molecular Weight | 320.517 | nRot | 15 |
| Heavy Atom Molecular Weight | 284.229 | nRig | 4 |
| Exact Molecular Weight | 320.272 | nRing | 0 |
| Solubility: LogS | -6.56 | nHRing | 0 |
| Solubility: LogP | 7.245 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 60.6785 |
| nHD | 0 | BPOL | 38.7195 |
| QED | 0.195 |
| Synth | 2.578 |
| Natural Product Likeliness | 1.089 |
| NR-PPAR-gamma | 0.452 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.034 |
| HIA | 0.009 |
| CACO-2 | -4.559 |
| MDCK | 0.0000192 |
| BBB | 0.228 |
| PPB | 0.962225 |
| VDSS | 2.624 |
| FU | 0.0221175 |
| CYP1A2-inh | 0.932 |
| CYP1A2-sub | 0.157 |
| CYP2c19-inh | 0.548 |
| CYP2c19-sub | 0.059 |
| CYP2c9-inh | 0.741 |
| CYP2c9-sub | 0.953 |
| CYP2d6-inh | 0.17 |
| CYP2d6-sub | 0.148 |
| CYP3a4-inh | 0.721 |
| CYP3a4-sub | 0.063 |
| CL | 8.575 |
| T12 | 0.3 |
| hERG | 0.021 |
| Ames | 0.07 |
| ROA | 0.004 |
| SkinSen | 0.981 |
| Carcinogencity | 0.626 |
| EI | 0.957 |
| Respiratory | 0.855 |
| NR-Aromatase | 0.36 |
| Antiviral | No |
| Prediction | 0.590773 |